A massive international trade deal currently being negotiated would raise drug prices in the U.S. and abroad, said two House Democrats during a conference call with reporters. The legislators emphasized that American negotiators, not foreign stakeholders, are the ones pushing hardest to promote the interests of brand-name drug companies at the risk of endangering public health.